Schorno Dean L

Average Profitability
2.44%
Insider Buys Quantity
1
Insider Buys Sum
$106,544.11
Insider Sells Quantity
5
Insider Sells Sum
$103,898.79

Insider Activity of Schorno Dean L

According to the SEC Form 4 filings, Schorno Dean L, being in a position of

  1. EVP & Chief Financial Officer at Rigel Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3770 shares for $80,615,
    over all time since 2019-05-22, has bought 50000 shares for $106,544, and sold 21787 shares for $103,899.

The largest purchase of all time was on 2019-05-22 and amounted to 50000 shares of Rigel Pharmaceuticals, Inc. for $106,544.

The largest sale of all time was on 2025-02-04 and amounted to 2036 shares of Rigel Pharmaceuticals, Inc. for $42,595.

Biography of Schorno Dean L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$80,6152100

Comparison of Insiders on Amount of Buys and Sells

2025-02-05SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & Chief Financial Officer
1,734
0.0103%
$21.93$38,020-8.36%
2025-02-04SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & Chief Financial Officer
2,036
0.0114%
$20.92$42,595+0.64%
2024-02-05SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & Chief Financial Officer
7,027
0.0037%
$1.14$8,011+14.62%
2024-02-02SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & Chief Financial Officer
5,601
0.0029%
$1.13$6,327+17.54%
2023-02-02SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & Chief Financial Officer
5,389
0.0029%
$1.66$8,946-28.81%
2019-05-22PurchaseRigel Pharmaceuticals, Inc.
RIGL
EVP &Chief Financial Officer
50,000
0.0311%
$2.13$106,544+2.44%
Total: 6
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.